Postmarketing adverse drug reactions A duty to report?

Eran Klein; Dennis Bourdette

doi:10.1212/CPJ.0b013e3182a1b9f0

Postmarketing adverse drug reactions A duty to report?

Eran Klein, Dennis Bourdette

Neurology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.

Original language	English (US)
Pages (from-to)	288-294
Number of pages	7
Journal	Neurology: Clinical Practice
Volume	3
Issue number	4
DOIs	https://doi.org/10.1212/CPJ.0b013e3182a1b9f0
State	Published - Aug 2013

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/CPJ.0b013e3182a1b9f0

Fingerprint Dive into the research topics of 'Postmarketing adverse drug reactions A duty to report?'. Together they form a unique fingerprint.

Cite this

@article{848efa2e4e5e449d8c4e242d810c2688,

title = "Postmarketing adverse drug reactions A duty to report?",

abstract = "Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.",

author = "Eran Klein and Dennis Bourdette",

year = "2013",

month = aug,

doi = "10.1212/CPJ.0b013e3182a1b9f0",

language = "English (US)",

volume = "3",

pages = "288--294",

journal = "Neurology: Clinical Practice",

issn = "2163-0402",